Literature DB >> 8370666

cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III).

Y Ihara1, A Nishikawa, T Tohma, H Soejima, N Niikawa, N Taniguchi.   

Abstract

UDP-N-acetylglucosamine:beta-D-mannoside beta 1,4 N-acetylglucosaminyltransferase III (GnT-III) [EC 2.4.1.144] catalyzes the addition of N-acetylglucosamine in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-linked sugar chains to produce a bisecting GlcNAc residue. We have isolated six independent cDNA clones of human GnT-III from a fetal liver cDNA library. The cDNA sequence has an open reading frame that predicts a protein of 531 amino acids. The homology to rat GnT-III is 86% at the nucleotide level and is 91% at the amino acid level. The amino-terminal transmembrane domain and the catalytic domain are well conserved in the two species. Human GnT-III has a deletion of four amino acids in the "neck" region and several differences in the COOH-terminal region compared with the rat sequence. Using one of the human cDNA clones as the probe, two overlapping genomic clones have been isolated from a human cosmid library. The GnT-III gene has been mapped to chromosome 22q.13.1 using fluorescence in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370666     DOI: 10.1093/oxfordjournals.jbchem.a124105

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  16 in total

Review 1.  Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases.

Authors:  N Taniguchi; Y Ihara
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

2.  N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.

Authors:  Jianhui Fan; Shujing Wang; Shengjin Yu; Jingna He; Weilong Zheng; Jianing Zhang
Journal:  Glycoconj J       Date:  2012-06-27       Impact factor: 2.916

Review 3.  Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.

Authors:  Naoyuki Taniguchi; Motoko Takahashi; Yasuhiko Kizuka; Shinobu Kitazume; Vladimir V Shuvaev; Tomomi Ookawara; Akiko Furuta
Journal:  Glycoconj J       Date:  2016-06-21       Impact factor: 2.916

4.  Effects of dibutyryl cAMP and bromodeoxyuridine on expression of N-acetylglucosaminyltransferases III and V in GOTO neuroblastoma cells.

Authors:  Y Ihara; A Nishikawa; N Taniguchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

5.  Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation.

Authors:  Qingsong Xu; Ryota Akama; Tomoya Isaji; Yingying Lu; Hirokazu Hashimoto; Yoshinobu Kariya; Tomohiko Fukuda; Yuguang Du; Jianguo Gu
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

Review 6.  The joys of HexNAc. The synthesis and function of N- and O-glycan branches.

Authors:  H Schachter
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

7.  A novel second isoenzyme of the human UDP-N-acetylglucosamine:alpha1,3-D-mannoside beta1,4-N-acetylglucosaminyltransferase family: cDNA cloning, expression, and chromosomal assignment.

Authors:  A Yoshida; M T Minowa; S Takamatsu; T Hara; H Ikenaga; M Takeuchi
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

Review 8.  Glycosyltransferases and non-alcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Hai-Ying Su; Wei An
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

9.  Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.

Authors:  Eun-Young Song; Kyung-Sook Kim; Kyoung-A Kim; Yung-Dai Kim; Dur-Han Kwon; Si-Myung Byun; Hee-Jung Kim; Tae-Wook Chung; Yong-Kyung Choe; Tai-Wha Chung; Cheorl-Ho Kim
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

10.  Changes of beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in patients with leukaemia.

Authors:  M Yoshimura; Y Ihara; N Taniguchi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.